Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gene clue hunt in back and joint disease

NCT ID NCT07507487

Not yet recruiting Knowledge-focused Sponsor: Asmaa Hassan mohamed Abdel Mawjoud Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will measure the activity of a gene called TNFAIP3 in 110 people with ankylosing spondylitis or psoriatic arthritis. The goal is to see if the gene's expression is linked to how active the disease is. Researchers will use a blood test to check gene levels and compare them to disease symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help researchers understand the role of the TNFAIP3 gene in these inflammatory diseases, potentially pointing toward new treatment targets.
What could go wrong
This is an observational study, not a treatment trial. It is very early and only looks at gene expression, so it may not lead directly to any new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosing spondylitis psoriatic arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.